Take a look at the businesses making headlines in prolonged buying and selling. SolarEdge — The photo voltaic inventory cratered 23% after SolarEdge posted a dismal third-quarter report and outlook for the present quarter’s income. SolarEdge misplaced 55 cents per share, excluding objects, whereas analysts polled by LSEG, previously often known as Refinitiv, forecast a acquire of 89 cents per share. Income additionally underwhelmed within the quarter, with the corporate posting $725 million in opposition to a $768 million consensus estimate. The corporate guided income for the present quarter to between $300 million and $350 million, properly beneath the $688 million anticipated by analysts. Qualcomm — Shares of the wi-fi tech firm jumped 3.6%. Qualcomm surpassed analysts’ estimates in its fiscal fourth quarter, reporting adjusted earnings of $2.02 per share on income of $8.67 billion. Analysts polled by LSEG anticipated earnings of $1.91 per share and income of $8.51 billion. Etsy — The net market’s shares tumbled 3%. CEO Josh Silverman warned of a difficult outlook for discretionary spending, saying “this unstable macro local weather will make it difficult for us to develop this quarter.” Etsy beat analysts’ estimates for earnings within the third quarter however fell wanting Wall Avenue’s expectations on income. Digital Arts — The gaming inventory climbed 3.5% after beating analysts’ consensus forecasts for web bookings within the fiscal second quarter. Digital Arts additionally issued steerage for the present quarter and full 12 months that was largely in step with expectations. Roku — Shares of the streaming video firm jumped 16% after Roku’s third-quarter income topped expectations. The corporate generated $912 million of income, in comparison with the $855 million predicted by Wall Avenue analysts, in keeping with LSEG. Roku’s fourth-quarter steerage for income and a key profitability metric additionally topped expectations, in keeping with Avenue Account. DoorDash — The meals supply inventory popped 7% in prolonged buying and selling. DoorDash reported a lack of 19 cents per share on income of $2.16 billion. Analysts polled by LSEG known as for a 40 cent loss per share and income of $2.09 billion. Tandem Diabetes Care — The insulin firm sank 18% postmarket after reporting a third-quarter loss per share of 51 cents, wider than analysts’ estimated lack of 48 cents, in keeping with FactSet. Income of $185.6 million additionally missed an estimate of $192.9 million. Full-year income steerage of $765 million was $20 million beneath the prior forecast and missed analysts’ consensus of $788 million. e.l.f. Magnificence — The cosmetics inventory popped 5% after surpassing Avenue expectations and elevating its full-year steerage for the second quarter in a row. For the second fiscal quarter, the corporate posted 82 cents in adjusted earnings per share and $215.5 million in income, whereas analysts surveyed by LSEG had forecast 53 cents on income of $197.1 million. Airbnb — The holiday rental platform fell nearly 3% after saying fourth-quarter income will whole $2.13 billion to $2.17 billion, versus a consensus FactSet analysts’ estimate of $2.18 billion, and fourth-quarter nights booked will average in comparison with the prior three-month interval. Clorox — Shares of the patron items large jumped 7%. Clorox posted fiscal first-quarter income of $1.39 billion, whereas analysts known as for estimates of $1.31 billion. Zillow Group — Shares slid 3% after the actual property model guardian stated the variety of common month-to-month distinctive customers and visits have been each down within the third quarter in comparison with the identical three-month interval a 12 months prior. That overshadowed an earnings report that in any other case exceeded analysts’ expectations for the quarter. Mondelez Worldwide — The snack maker traded 3% larger after beating expectations for the third quarter and elevating full-year steerage. The corporate recognized for Oreo and Ritz reported 82 cents per share in earnings, excluding objects, on $9.03 billion in income. Analysts surveyed by LSEG anticipated 79 cents in earnings per share and income at $8.83 billion. Sarepta Therapeutics — The biopharmaceutical inventory superior 1.6% after notably outperforming Wall Avenue expectations within the third quarter. Sarepta stated it misplaced 46 cents per share and noticed a income of $331.8 million. In the meantime, analysts polled by FactSet anticipated a a lot bigger lack of $1.22 per share on income of $285.3 million. — CNBC’s Darla Mercado, Sarah Min, Jesse Pound and Scott Schnipper contributed reporting.
